Geode Capital Management
ARTL icon

Geode Capital Management’s Artelo Biosciences ARTL Stock Holding History

Geode Capital Management’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Buy
+1,540
New +$39.7K ﹤0.01% 4393
2026
Q1 		– Sell
-422
Closed -$13.9K – 4521
2025
Q4 		$13.9K Buy
+422
New +$29.5K ﹤0.01% 4413
2025
Q3 		– Sell
-594
Closed -$213K – 4482
2025
Q2 		$213K Buy
594
+429
+260% +$71.4K ﹤0.01% 3852
2025
Q1 		$23.4K Buy
165
+58
+54% +$10.5K ﹤0.01% 4320
2024
Q4 		$18.4K Hold
107
– – ﹤0.01% 4394
2024
Q3 		$19.8K Sell
107
-15
-12% -$3.09K ﹤0.01% 4395
2024
Q2 		$27.7K Hold
122
– – ﹤0.01% 4399
2024
Q1 		$29.7K Hold
122
– – ﹤0.01% 4413
2023
Q4 		$27.5K Hold
122
– – ﹤0.01% 4462
2023
Q3 		$28.9K Buy
122
+37
+44% +$11.1K ﹤0.01% 4547
2023
Q2 		$27.6K Hold
85
– – ﹤0.01% 4613
2023
Q1 		$31.8K Hold
85
– – ﹤0.01% 4616
2022
Q4 		$39K Buy
85
+8
+10% +$3.75K ﹤0.01% 4658
2022
Q3 		$43K Hold
77
– – ﹤0.01% 4796
2022
Q2 		$59K Buy
77
+8
+12% +$7.08K ﹤0.01% 4738
2022
Q1 		$75K Buy
69
+2
+3% +$2.07K ﹤0.01% 4730
2021
Q4 		$84K Hold
67
– – ﹤0.01% 4769
2021
Q3 		$128K Buy
67
+9
+16% +$20.6K ﹤0.01% 4601
2021
Q2 		$167K Hold
58
– – ﹤0.01% 4402
2021
Q1 		$230K Buy
58
+33
+132% +$127K ﹤0.01% 4070
2020
Q4 		$44K Buy
+25
New +$38.7K ﹤0.01% 4188

Other funds holding ARTL

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Geode Capital Management's ARTL Position: Q2 2026 in Review

Geode Capital Management opened a new position in Artelo Biosciences (ARTL) in Q2 2026: 1,540 shares worth $15.5K. The stake represents ﹤0.01% of the portfolio and ranks #4393 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in ARTL as recently as Q4 2025.

Geode Capital Management first reported a position in ARTL in Q4 2020 and has held it in 21 quarters since. The position peaked at $230K in Q1 2021. 7 funds tracked by Wall St. Rank hold ARTL as of Q2 2026.

  • Geode Capital Management held 1,540 shares of Artelo Biosciences worth $15.5K as of Q2 2026.
  • Artelo Biosciences was a new Geode Capital Management position in Q2 2026.
  • Artelo Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4393 holding.
  • Geode Capital Management first reported a position in Artelo Biosciences in Q4 2020 and has held it in 21 quarters since.
  • Geode Capital Management's Artelo Biosciences position peaked at $230K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Artelo Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.